University of Sussex
Browse
s41375-021-01322-1.pdf (716.63 kB)

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Download (716.63 kB)
journal contribution
posted on 2023-06-10, 00:15 authored by Andrea PepperAndrea Pepper, Antonella Zucchetto, Kevin Norris, Erika Tissino, Jerry Polesel, Zarni Soe, David Allsup, Anna Hockaday, Pei Loo Ow, Peter Hillmen, Andrew Rawstron, Daniel Catovsky, Pietro Bulian, Riccardo Bomben, Duncan M Baird, Christopher D Fegan, Valter Gattei, Christopher PepperChristopher Pepper
No description supplied

Funding

Equipment Grant - Flow cytometer for cancer research; G2599; SUSSEX CANCER FUND FOR TREATMENT AND RESEARCH

ISSF pilot: In-vitro modelling and therapeutic targeting in lymphoid leukaemia; WELLCOME TRUST

History

Publication status

  • Published

File Version

  • Published version

Journal

Leukemia

ISSN

0887-6924

Publisher

Springer Nature

Volume

36

Page range

271-274

Event location

England

Department affiliated with

  • Clinical and Experimental Medicine Publications

Full text available

  • Yes

Peer reviewed?

  • Yes

Legacy Posted Date

2021-06-30

First Open Access (FOA) Date

2021-06-30

First Compliant Deposit (FCD) Date

2021-06-30

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC